Fact CheckerSign in

NCT05756361Completed

Family-Based Treatment for Type 1 Diabetes

A Family-Based Approach to Treat Obesity and Its Co-morbidities in Youth With Type 1 Diabetes (T1D) and Their Parents

Source: ClinicalTrials.gov · Last updated 30 Jun 2026

Brief summary (registry, in English)

Type 1 Diabetes carries high burden for affected youth and their families. Advances in insulin therapy and technology have been associated with increased obesity with 1/3 adolescents being overweight/obese. Since obesity runs in families and carries risk for poor outcomes psychologically and medically, the investigators are adapting our successful evidence-based Family Based Treatment for hybrid delivery to improve obesity and metabolic control in the affected youth and improve obesity and related co-morbidities in their parents.

Status (registry)
Completed
Study type
Interventional
Enrollment
22 (actual)
First submitted
9 Feb 2023
Start date
26 Apr 2023
Primary completion date
7 Jul 2025
Lead sponsor
State University of New York at Buffalo
NCT number
NCT05756361

What you commit to

  • Study type: Interventional
  • Participants enrolled: 22
  • From 26 Apr 2023 to the primary completion date, 7 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Child:
    • Chronic conditions other than T1D
    • Other autoimmune conditions other then T1D or autoimmune thyroiditis.
    • Medications that can affects weight, such as medications used to treat Attention Deficit Disorder or high dose steroids used to treat asthma.
    • Depression symptoms by standard of care Patient Health Questionnaire (PHQ) 9 in the child or parent
    • Inability to perform at least mild physical activity such as walking
    • Child with handicap (such as developmental delay or deafness) that would prevent him/her from benefitting from counseling in person and/or remotely Participating parent with
    • symptoms of depression assessed by standard of care PHQ
    • autoimmune disorders other than T1D or autoimmune thyroiditis
    • Participating parents with chronic disorder that is treated with medications that interfere with weight loss or are preventing him/her from performing at least mild physical activity

Who the study is looking for

  • T1D of 12 or more months duration
  • Age 6-17-years
  • Presence of overweight/obesity
  • Youth uses a pump for insulin delivery and a continuous glucose monitoring device to monitor glycemic levels
  • Youth has one parent with overweight/obesity willing to participate in the program

Age in the registry: 6 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Conventus
Coordinator of this site? Confirm its status
BuffaloUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.